IHS Chemical Week

World News and Views :: Top of the News

Clinigen and PCAS Sign API Supply Deal

3:58 AM MST | January 6, 2012 | Deepti Ramesh

Clinigen Healthcare, a division of Clinigen Group (Burton-on-Trent, U.K.), has signed a long-term global supply agreement with PCAS (Longjumeau, France), a leading active pharmaceutical ingredient (API) manufacturer, for the production of the Foscavir drug substance. PCAS will manufacture foscarnet sodium hexahydrate, the API contained in Clinigen’s Foscavir, while Clinigen will leverage its own infrastructure and global network of partners to supply the medicine worldwide, under the agreement. Clinigen holds marketing authorizations to sell Foscavir as a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa